237 related articles for article (PubMed ID: 35814368)
1.
Jiang F; Huang X; Yang X; Zhou H; Wang Y
Front Oncol; 2022; 12():795971. PubMed ID: 35814368
[TBL] [Abstract][Full Text] [Related]
2. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
Front Oncol; 2021; 11():656509. PubMed ID: 34178642
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adenocarcinoma.
Sun ZY; Wang W; Gao H; Chen QF
J Cancer; 2020; 11(10):2921-2934. PubMed ID: 32226507
[No Abstract] [Full Text] [Related]
4. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():921200. PubMed ID: 35774125
[TBL] [Abstract][Full Text] [Related]
5. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
8. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma.
Jiang Y; You J; Wu C; Kang Y; Chen F; Chen L; Wu W
J Clin Lab Anal; 2022 Oct; 36(10):e24691. PubMed ID: 36085578
[TBL] [Abstract][Full Text] [Related]
9. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
Yu L; Qiao R; Xu J; Han B; Zhong R
Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
[TBL] [Abstract][Full Text] [Related]
10. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
Front Oncol; 2020; 10():598437. PubMed ID: 33569346
[TBL] [Abstract][Full Text] [Related]
11. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma.
Jiang F; Liang M; Huang X; Shi W; Wang Y
PeerJ; 2021; 9():e11697. PubMed ID: 34268011
[TBL] [Abstract][Full Text] [Related]
12. High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma.
Zhang H; Yan X; Gu H; Xue Q; Liu X
J Thorac Dis; 2022 Dec; 14(12):4785-4802. PubMed ID: 36647484
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of
Deng P; Zhou R; Zhang J; Cao L
J Cancer; 2021; 12(11):3239-3248. PubMed ID: 33976733
[No Abstract] [Full Text] [Related]
14. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z
BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807
[TBL] [Abstract][Full Text] [Related]
15. High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation.
Wu Z; Zhuo T; Li Z; Zhu Y; Wu J; Liang G; Dai L; Wang Y; Tan X; Chen M
J Cancer; 2023; 14(12):2301-2314. PubMed ID: 37576392
[No Abstract] [Full Text] [Related]
16. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
17. INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment.
Zhang X; Zhang X; Jiang D; Zheng W; Wang H; Tian Y; Cheng B
Transl Oncol; 2023 Jul; 33():101679. PubMed ID: 37105130
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
20. B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma.
Wu Y; Luo J; Li H; Huang Y; Zhu Y; Chen Q
Ann Transl Med; 2022 Mar; 10(6):295. PubMed ID: 35434016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]